Investor · 1 deal

University of Otago

Dunedin

Disclosed deals

Every published round University of Otago took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.

Company	Stage	Announced	Amount	Role	Alongside	Sources
Amaroq Therapeutics	Unnamed stage	8 Jul 2021	$14m	Participant	Brandon Capital Otago Innovation Ltd NZ Innovation Booster Cure Kids Ventures	Brandon Capital portfolio (Mon 4 Apr 2022), Brandon BioCatalyst portfolio (Mon 4 Apr 2022), Brandon BioCatalyst portfolio (Thu 8 Jul 2021), Brandon Capital portfolio (Thu 8 Jul 2021), Brandon Capital portfolio (Thu 8 Jul 2021), Brandon BioCatalyst portfolio (Thu 8 Jul 2021)

Portfolio

Companies University of Otago has backed in a published round, and companies whose existing shares it bought off another holder.

Company	What it does	First invested	Rounds	Led
Amaroq Therapeutics		8 Jul 2021	1	0

Funds

Fund closes reported for University of Otago, as distinct from the investments it has made.

Fund	Announced	Committed	Target	Close	Sources
No fund closes recorded for University of Otago yet.

Portfolio companies acquired

Companies University of Otago has backed that another company then bought. An exit for the holding, not a deal University of Otago did.

Company	Bought by	Kind	Announced	Price
No portfolio company of University of Otago is recorded as having been acquired.

People

Name	Role	Sources

Something wrong? Tell us

University of Otago

Disclosed deals

Portfolio

Funds

Portfolio companies acquired

People

Coverage

Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa

Why We Invested in Sahha AI

Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board

$14m invested in world-leading RNA therapy: University of Otago spinout targeting new cancer treatments